Workflow
Here is Why Growth Investors Should Buy Merit Medical (MMSI) Now
MMSIMerit Medical(MMSI) ZACKS·2025-02-21 18:45

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying the right ones can be challenging due to associated risks and volatility [1] Group 1: Company Overview - Merit Medical (MMSI) is highlighted as a recommended growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] - The company is a manufacturer of disposable medical devices, which positions it well in the growth stock category [3] Group 2: Earnings Growth - Merit Medical has a historical EPS growth rate of 21.5%, with projected EPS growth of 11.2% for the current year, significantly outperforming the industry average of 6.6% [5] Group 3: Cash Flow Growth - The year-over-year cash flow growth for Merit Medical stands at 12.2%, compared to an industry average of -0.2%, indicating strong cash generation capabilities [6] - The company's annualized cash flow growth rate over the past 3-5 years is 11.5%, while the industry average is only 2.1% [7] Group 4: Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Merit Medical, with the Zacks Consensus Estimate for the current year increasing by 0.5% over the past month [8] Group 5: Investment Potential - Merit Medical has achieved a Growth Score of B and a Zacks Rank 2, suggesting it is a solid choice for growth investors and a potential outperformer [10]